NEUARTIGES ENDOLYSINPOLYPEPTID

Patent europeic · EP3350322 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3350322
Numer da la dumonda
EP16763819
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
12-09-2016
Publitgà
25-07-2018
Concedì
28-04-2021
Stritgà
02-05-2022
Motiv
Taxa annuala betg pajada
Classas IPC
C12N 9/36 (2006.01)
C07K 14/31 (2006.01)
A61K 38/47 (2006.01)
A61K 38/00 (2006.01)
A61P 31/04 (2006.01)
Prioritad
EP 15185337 15.09.2015
Dumonda PCT
PCT/EP2016/071405 12.09.2016
Publicaziun PCT
WO2017/046021 23.03.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 02-05-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 02.05.2022

  2. 09-03-2022

    Midada

    Published in Swissreg on 09.03.2022

  3. 28-04-2021

    Concedì

    Published in Swissreg on 28.04.2021

Partidas

Possessur

Micreos Human Health B.V.

Bankaplein 2, 2585 EV Den Haag, NL

Inventur

LOESSNER, Martin Johannes

8123 Ebmatingen

EICHENSEHER, Fritz

8050 Zürich

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.